Lazard Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.46M | Sell |
7,831
-19,981
| -72% | -$6.27M | ﹤0.01% | 944 |
|
|
2025
Q1 | $8.47M | Sell |
27,812
-298
| -1% | -$90.8K | 0.01% | 528 |
|
|
2024
Q4 | $9.34M | Buy |
28,110
+3,303
| +13% | +$1.1M | 0.01% | 485 |
|
|
2024
Q3 | $8.28M | Sell |
24,807
-49,578
| -67% | -$16.5M | 0.01% | 499 |
|
|
2024
Q2 | $30.6M | Buy |
74,385
+2,109
| +3% | +$869K | 0.04% | 295 |
|
|
2024
Q1 | $29.2M | Sell |
72,276
-10,680
| -13% | -$4.32M | 0.04% | 313 |
|
|
2023
Q4 | $25.4M | Buy |
82,956
+665
| +0.8% | +$204K | 0.03% | 335 |
|
|
2023
Q3 | $19.9M | Buy |
82,291
+2,110
| +3% | +$511K | 0.03% | 379 |
|
|
2023
Q2 | $19.3M | Sell |
80,181
-14,269
| -15% | -$3.43M | 0.02% | 410 |
|
|
2023
Q1 | $17.8M | Buy |
94,450
+12,598
| +15% | +$2.37M | 0.02% | 449 |
|
|
2022
Q4 | $17.4M | Buy |
81,852
+66,600
| +437% | +$14.1M | 0.02% | 450 |
|
|
2022
Q3 | $2.4M | Buy |
15,252
+13,014
| +582% | +$2.05M | ﹤0.01% | 847 |
|
|
2022
Q2 | $334K | Buy |
2,238
+1,547
| +224% | +$231K | ﹤0.01% | 1178 |
|
|
2022
Q1 | $113K | Sell |
691
-412
| -37% | -$67.4K | ﹤0.01% | 1364 |
|
|
2021
Q4 | $239K | Sell |
1,103
-13,201
| -92% | -$2.86M | ﹤0.01% | 1241 |
|
|
2021
Q3 | $2.71M | Buy |
+14,304
| New | +$2.71M | ﹤0.01% | 876 |
|
|
2021
Q2 | – | Sell |
-781
| Closed | -$128K | – | 2028 |
|
|
2021
Q1 | $128K | Buy |
781
+252
| +48% | +$41.3K | ﹤0.01% | 1167 |
|
|
2020
Q4 | $73K | Hold |
529
| – | – | ﹤0.01% | 1273 |
|
|
2020
Q3 | $59K | Sell |
529
-334
| -39% | -$37.3K | ﹤0.01% | 1133 |
|
|
2020
Q2 | $80K | Sell |
863
-423
| -33% | -$39.2K | ﹤0.01% | 1076 |
|
|
2020
Q1 | $94K | Buy |
1,286
+513
| +66% | +$37.5K | ﹤0.01% | 1011 |
|
|
2019
Q4 | $64K | Buy |
773
+380
| +97% | +$31.5K | ﹤0.01% | 1012 |
|
|
2019
Q3 | $33K | Buy |
+393
| New | +$33K | ﹤0.01% | 1019 |
|